ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for charts Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.

OKYO Okyo Pharma Limited

91,00
0,00 (0,00%)
14 Jun 2024 - Geschlossen
Verzögert um 15 Minuten
Name Symbol Markt Aktientyp
Okyo Pharma Limited OKYO London Ordinary Share
  Änderung Änderung % Aktuell Zeit
0,00 0,00% 91,00 02:00:00
Handelsbeginn Niedrig Hoch Schlusskurs Handelsende
91,00 91,00
more quote information »
Industriesektor
MINING

Aktuelle News

Datum Zeit Quelle Überschrift
08.5.202413:00UKREGOKYO Pharma Announces Participation in May 2024 Investor..
30.4.202413:00UKREGOKYO Pharma Announces Upcoming Presentation of OK-101 Phase..
09.4.202401:00UKREGOKYO Pharma to Reschedule Key Opinion Leader Event in Dry..
02.4.202413:00UKREGOKYO Pharma Announces Upcoming Presentation of OK-101 Phase..
22.3.202412:00UKREGOKYO Pharma Announces OK-101 Successfully Achieved..
21.3.202412:00UKREGOKYO Pharma to Host Key Opinion Leader Event to Discuss New..
20.3.202412:00UKREGOKYO Pharma to Release New and Comprehensive Data from Phase..
09.2.202413:36IHNWOKYO Pharma Receives FDA Approval of IND for OK-101 in..
09.2.202413:00UKREGOKYO Pharma Receives FDA Approval of IND for OK-101 in..
31.1.202413:00UKREGOKYO Pharma Announces Distinguished Ophthalmologists with..
08.1.202413:00GLOBEOKYO Pharma Announces OK-101 Successfully Achieved..
05.1.202415:30GLOBEOKYO Pharma to Present at the Biotech Showcase Conference in..
04.12.202313:00GLOBEOKYO Pharma Announces Last Patient Enrolled in OK-101 Phase..
31.10.202312:00GLOBEOKYO Pharma Announces $5.84 Million Cash Raise and Payables..
09.10.202313:00GLOBEOKYO Pharma Announces Filing of an Investigational New Drug..
05.10.202313:00GLOBEOKYO Pharma Announces Positive Safety Data Profile for the..
15.9.202313:00GLOBEOKYO Pharma Announces Closing of $4.0 Million Registered..
14.9.202315:15GLOBEOKYO Pharma Announces Pricing of $4.0 Million Registered..
14.9.202314:45GLOBEOKYO Pharma Limited Announces Withdrawal of Public Offering
13.9.202322:05GLOBEOKYO Pharma Announces Public Offering of Ordinary Shares
08.9.202313:00GLOBEOKYO Pharma Completes Enrollment in Phase 2 Clinical Trial..
30.8.202313:00GLOBEOKYO Pharma Achieves 90% Enrollment in 240-Patient Phase 2..
29.8.202313:00GLOBEOKYO Pharma Limited Regains Compliance with Nasdaq Listing..
15.8.202315:00GLOBEOKYO Pharma Limited Reports Annual Results for the Twelve..
31.7.202308:18GLOBEOKYO Pharma Limited Announces Withdrawal of Public Offering
28.7.202323:25GLOBEOKYO Pharma Announces Proposed Public Offering of Ordinary..
28.7.202323:05GLOBEOKYO Pharma Limited Receives Nasdaq Deficiency Notice
28.7.202313:01GLOBEOKYO Pharma Plans to Initiate Phase 2 Trial of OK-101 in..
27.7.202317:30GLOBEOKYO Pharma Announces Appointment of William A. Clementi as..

Kürzlich von Ihnen besucht

Delayed Upgrade Clock